Man-made vitreous fibres.

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71

Listing occupational carcinogens. Environ Health Perspect (2004) 3.57

Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.64

Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Part Fibre Toxicol (2009) 1.10

The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles. Part Fibre Toxicol (2009) 1.06

Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med (2006) 0.98

A short history of the toxicology of inhaled particles. Part Fibre Toxicol (2012) 0.95

Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity. Environ Health (2014) 0.93

Behavior of new type of rock wool (HT wool) in lungs after exposure by nasal inhalation in rats. Environ Health Prev Med (2005) 0.82

Case report: analytical electron microscopy of lung granulomas associated with exposure to coating materials carried by glass wool fibers. Environ Health Perspect (2010) 0.81

Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities. Carcinogenesis (2007) 0.77

Theoretical deposition of carcinogenic particle aggregates in the upper respiratory tract. Ann Transl Med (2013) 0.75

Behavior of rock wool in lungs after exposure by nasal inhalation in rats. Environ Health Prev Med (2009) 0.75

Effects of rock wool on the lungs evaluated by magnetometry and biopersistence test. J Occup Med Toxicol (2009) 0.75

Do insulation products of man-made vitreous fibres still cause skin discomfort? Contact Dermatitis (2014) 0.75

Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum (2004) 14.27

Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinog Risks Hum (2002) 4.46

Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr Eval Carcinog Risks Hum (2010) 4.14

Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum (2007) 3.30

Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum (2004) 3.29

Non-ionizing radiation, Part 1: static and extremely low-frequency (ELF) electric and magnetic fields. IARC Monogr Eval Carcinog Risks Hum (2002) 3.18

Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. IARC Monogr Eval Carcinog Risks Hum (2006) 2.92

Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum (2012) 2.82

Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum (2004) 2.50

Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum (2007) 2.06

Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum (2010) 1.95

Household use of solid fuels and high-temperature frying. IARC Monogr Eval Carcinog Risks Hum (2010) 1.75

Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum (2012) 1.73

IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr Eval Carcinog Risks Hum (2008) 1.71

Non-ionizing radiation, Part 2: Radiofrequency electromagnetic fields. IARC Monogr Eval Carcinog Risks Hum (2013) 1.69

Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide. IARC Monogr Eval Carcinog Risks Hum (2006) 1.66

Painting, firefighting, and shiftwork. IARC Monogr Eval Carcinog Risks Hum (2010) 1.66

Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. IARC Monogr Eval Carcinog Risks Hum (2004) 1.63

Arsenic, metals, fibres, and dusts. IARC Monogr Eval Carcinog Risks Hum (2012) 1.45

Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monogr Eval Carcinog Risks Hum (2007) 1.39

Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum (1995) 1.38

Inorganic and organic lead compounds. IARC Monogr Eval Carcinog Risks Hum (2006) 1.20

IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. IARC Monogr Eval Carcinog Risks Hum (2010) 1.19

Chemical agents and related occupations. IARC Monogr Eval Carcinog Risks Hum (2012) 1.16

Carbon black, titanium dioxide, and talc. IARC Monogr Eval Carcinog Risks Hum (2010) 1.03

DIESEL AND GASOLINE ENGINE EXHAUSTS AND SOME NITROARENES. IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS. IARC Monogr Eval Carcinog Risks Hum (2014) 0.98

Some chemicals present in industrial and consumer products, food and drinking-water. IARC Monogr Eval Carcinog Risks Hum (2013) 0.95

MALARIA AND SOME POLYOMAVIRUSES (SV40, BK, JC, AND MERKEL CELL VIRUSES). IARC Monogr Eval Carcinog Risks Hum (2014) 0.95

TRICHLOROETHYLENE, TETRACHLOROETHYLENE, AND SOME OTHER CHLORINATED AGENTS. IARC Monogr Eval Carcinog Risks Hum (2014) 0.90

Pharmaceuticals. Volume 100 A. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum (2012) 0.89

Radiation. IARC Monogr Eval Carcinog Risks Hum (2012) 0.77